Effects of etibatide combined with emergency percutaneous coronary intervention on blood perfusion and cardiac function in patients with acute myocardial infarction

Abstract

Objectives: To investigate the effects of etibatide combined with emergency percutaneous coronary intervention (PCI) on blood perfusion and cardiac function in acute myocardial infarction (AMI) patients.
 Methods: This was a prospective, randomized, controlled study. From November 2015 to June 2019, 196 patients with ST-segment elevation myocardial infarction (STEMI) undergoing emergency PCI admitted to Baoding First Central Hospital were enrolled. The 196 STEMI patients were randomly divided into experimental group and control group. In the experimental group, STEMI patients were treated with emergency PCI + etibatide; while in the control group, only PCI was performed. Observation indexes included: general data, myocardial perfusion and cardiac function indexes and major adverse cardiac events (MACE).
 Results: There was no significant difference in general data between the two groups (P > 0.05). The rate of ST-segment resolution (STR) in the experimental group was better than that in the control group (P < 0.05). In myocardial contrast echocardiography (MCE), higher peak intensity (PI) and shorter time-to-peak (TP) were observed in the experimental group compared with the control group (P < 0.05). The platelet aggregation rate was compared between the two group at the time points of before PCI, after PCI and two hour after drug withdrawal, and there was no significant change in the platelet aggregation rate of the control group between different time points (before PCI, after PCI and two hour after drug withdrawal); while the platelet aggregation rate of the experimental group was significantly lower after PCI and two hour after drug withdrawal than that before PCI (P < 0.05), and an obviously decreased platelet aggregation rate was found in the experimental group(P < 0.05). After three months of follow-up, there was one case of MACE in the experimental group and 1 case of MACE in the control group, without any difference in the incidence of MACE between the two groups (P > 0.05).
 Conclusion: Etibatide combined with emergency PCI could improve myocardial reperfusion and cardiac function in patients with acute STEMI without increasing the incidence of MACE.
 doi: https://doi.org/10.12669/pjms.37.1.2950
 How to cite this:Hu Y, Qi F, Yu L, Geng W. Effects of etibatide combined with emergency percutaneous coronary intervention on blood perfusion and cardiac function in patients with acute myocardial infarction. Pak J Med Sci. 2021;37(1):185-190. doi: https://doi.org/10.12669/pjms.37.1.2950
 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Cardio protective effect of nicorandil in reperfusion injury among patients undergoing primary percutaneous coronary intervention

“…Numerous studies have been conducted to evaluate the effect of medicines on ischemic heart tissue and its reperfusion complications using different parameters including cardiac biomarkers, ECG changes, TIMI scoring and major cardiovascular events (MACE). [19][20][21][22] In our study, we evaluated the cardio protective role of nicorandil in patients of STEMI who had undergone primary PCI. Nicorandil is being used clinically for treating chronic stable angina patients but its new mechanism of IP makes its role valuable in interventional procedure of PPCI.…”

Value of Cardiac Troponin, Myoglobin Combined with Heart-type Fatty Acid-binding Protein Detection in Diagnosis of Early Acute Myocardial Infarction

“…Although percutaneous coronary intervention (PCI) has made progress and been widely used, the mortality of patients with AMI is still high, and the treatment options are limited. 3 Therefore, early correct diagnosis and effective treatment are extremely important in reducing the mortality and improving the prognosis of patients with AMI. 4 For the diagnosis of MI, dynamic changes of ECG and myocardial enzymology are commonly used.…”